Odisha to Start Human Clinical Trial for COVID-19 Vaccine
Chiranjit Dhibar, a 30-year-old resident of West Bengal’s Durgapur, is set to become the first person to participate in the clinical trial of the COVID-19 vaccine in Odisha. Dhibar, who is a teacher, will soon take the antigen of the deadly virus.
Indian Council of Medical Research (ICMR) and Bharat Biotech, together, have developed the anti-COVID vaccine. Dhibar has volunteered to participate in the human trial phase for this vaccine. As per sources, Dhibar had applied to participate in the clinical trial in April. On 5th July, he got a confirmation call from the Patna centre of ICMR for a clinical trial. He confirmed this news via a Facebook wall post stating that he has been inspired by the principles of the RSS (Rashtriya Swayamsevak Sangh) and has decided to dedicate his body to the country.
The Drug Controller General of India – CDSCO (The Central Drugs Standard Control Organization) has passed approval for a human clinical trial of the two made-in-India coronavirus vaccines – COVAXIN and ZyCov-D. Both the vaccines have been approved for Phase II & Phase III trials.
The Union Ministry of Science and Technology has informed that more than 140 prospective COVID-19 vaccines are in various stages of development across the world. Out of these, 11 have entered the human trial phase.
Meanwhile, in the capital city Bhubaneswar, 46 new cases of COVID-19 have been reported in the last 24 hours. This makes it the highest single-day spike reported in the smart city. Of the 46 new infections, 24 are via local transmission, while 22 have been identified from various quarantine centres, informed Bhubaneswar Municipal Corporation (BMC) today. The current tally of COVID-19 cases in Bhubaneswar is at 525, out of which 222 are active cases.